35 devices · GMDN 56811
B-cell specific activator protein (BSAP) IVD antibodies are laboratory reagents designed to detect the Pax-5 protein in clinical samples. Clinically, they help diagnose or monitor conditions linked to Pax-5 expression, such as certain leukemias or lymphoproliferative disorders by identifying its presence or levels in tissue or cell samples.
These devices are typically in-vitro diagnostics (IVDs) and may be supplied as monoclonal or polyclonal antibodies, often pre-diluted or ready-to-use. Regulation varies by jurisdiction, but they are generally classified based on risk and intended use, with oversight from agencies like the FDA or EU MDR. Availability depends on local market approvals and clinical laboratory requirements.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.